Hyperprolactinemia: Clinical Trials

3 trials for Hyperprolactinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Unknown 1

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
Aripiprazole - Schizophrenia
Not applicableUnknownBeijing HuiLongGuan Hospital1202013-02-012013-12-17
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Aripiprazole, Placebo - Hyperprolactinemia
Not applicableCompletedUniversity of Maryland, Baltimore602011-01-012019-09-27
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
Metformin - Metabolic Disturbance, Hyperprolactinemia
Not applicableCompletedTaipei Medical University Hospital422010-05-312024-03-22

Narrower conditions

Schizophrenia (3)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Endocrine System Diseases (3)  ·  Hyperpituitarism (3)  ·  Hypothalamic Diseases (3)  ·  Mental Disorders (3)  ·  Nervous System Diseases (3)  ·  Pituitary Diseases (3)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (3)

Interventions

Aripiprazole (2)  ·  Metformin (1)

Sponsors

Beijing HuiLongGuan Hospital (1)  ·  Taipei Medical University Hospital (1)  ·  University of Maryland, Baltimore (1)

Countries

China (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Deanna L Kelly, Pharm.D., BCPP (1)  ·  Mong-Liang Lu, MD (1)